The application of conventional organic solvents is essential in several steps of bioprocesses in order to achieve sufficient economic efficiency. The use of organic solvents is frequently used either to partly or fully replace water in the reaction medium or as a process aid for downstream separation. Nowadays, manufacturers are increasingly requested to avoid and substitute solvents with hazardous potential. Therefore, the solvent selection must account for potential environmental hazards, health and safety problems, in addition to fulfilling the ideal characteristics for application in a process. For the first time, criteria including Environment, Health and Safety (EHS), as well as the technical requirements for reaction and separation have been reviewed, collected and integrated in a single organic solvent screening strategy to be used as a guideline for narrowing down the list of solvents to test experimentally. Additionally, we have also included a solvent selection guide based on the methodology developed in the Innovative Medicines Initiative CHEM21 (IMI CHEM21) project and applied specifically to water-immiscible solvents commonly used in bioprocesses.
Introduction
There is currently significant interest in the application of biotechnology to chemical manufacture, driven in part by the need to replace (or at least minimize) existing fossil feedstocks by renewable and sustainable ones. Likewise the chemical industry, and perhaps even more importantly the pharmaceutical industry, needs to use ever cleaner processes, with reduced reagent use and waste generation. For example, while the E factor is a measure of the amount of waste produced in a process (E factor = kg waste / kg product) (Sheldon, 2017) , it is perhaps more useful to examine the composition of the waste from a given process. This quickly motivates the need to reduce or replace the use of organic solvents, applied primarily for product recovery and purification. For this reason several pharmaceutical companies, academic groups and organisations like the ACS Green Chemistry Institute (GCI) Pharmaceutical Roundtable have successfully driven an agenda of solvent reduction and replacement (Constable et al., 2007; Jessop et al., 2015; Tucker and Faul, 2016) . To a large extent this has been focused on chemical synthetic strategies. However, while this serves as a very valuable guidance for today, the range of industrial processes is changing. For example, already today several hundred small-molecule pharmaceutical production processes use one or more bioprocess steps (Buchholz et al., 2012; Meyer et al., 2013; Woodley, 2017) . Indeed as industrial interest in cleaner synthesis grows it becomes clear that in the future many more bioprocesses will be implemented in industry (Cue and Zhang, 2009; Sheldon and Woodley, 2017) . Even if fermentation and biocatalysis were to replace a significant fraction of the synthetic reactions in the fine chemical and pharmaceutical industry, it remains the case that the products still need to be recovered and purified. The downstream separation can include many potential unit operations which are dependent upon the product (as well as by-product and substrate) properties. Nevertheless, for most biocatalytic reactions and fermentations the product is often toxic (leading to an irreversible loss of activity) or inhibitory (leading to a reversible loss of activity) to the biocatalyst/microorganism at concentrations much lower than are the minimum required to feed a conventional downstream process. This has been the major motivation behind the implementation of in situ product removal (ISPR), where inhibitory or toxic products are removed during the reaction (either at the site of the reaction, or else in a recycle loop) ( Woodley et al., 2008) . Of particular interest is that polymers have been used in many ISPR solutions (Phillips et al., 2013) and can potentially be an effective, safer and cheaper alternative to the use of organic solvents (Dafoe and Daugulis, 2014). Regardless of the type of phase used to recover product it is clear that systematic selection methods are required. On this premise we recognized that one of the most used separation methods (aqueous-organic liquidliquid extraction) could in particular benefit from a more systematic screening procedure for the organic solvent. In this review, for the first time, the criteria to screen for solvents for a bioprocess are integrated in a single report, accounting for both the technical, as well as EHS requirements which as we have indicated earlier are a prerequisite for industrial implementation. The collection of these criteria forms the basis of a screening procedure in particular focused on biphasic systems in bioprocesses in order to narrow down the number of solvents to be tested experimentally. In this paper in contrast to previous publications (Elgue et al., 2006; Gani, 2006; Zhou et al., 2014) , we deliberately restrict ourselves to bioprocesses using enzymes or microorganisms, to manufacture chemical products. We consider this screening procedure essential for the scientific community involved in the early stage development and research of new bioprocesses. Interestingly, this rationale is supported by journals such as ChemSusChem (Kemeling, 2012) which has specifically asked authors to justify their choice of solvents in submitted manuscripts and if possible to consider replacing harmful ones.
Use of organic solvents in bioprocesses
Whilst the use of water-miscible organic solvents (e.g. ethanol, dimethyl sulfoxide) to help solubilize poorly-water soluble organic compounds in single phase biocatalytic systems has been widely reported in the scientific literature, such systems may give only a 10-20% increase in substrate and/or product concentration (Sheldon and Pereira, 2017) . Additionally, with only a few exceptions, such polar solvents strip essential water from the biocatalyst resulting in a loss of enzyme stability (Gorman and Dordick, 1992; Kamal et al., 2013; Taher and Al-Zuhair, 2017; Yang et al., 2004) . On the other hand, essentially water-immiscible organic solvents (containing only small amounts of water, at concentrations less than saturation) like n-hexane, t-butyl methyl ether etc. can be used for lipase reactions run in a synthetic direction (to avoid hydrolysis) (Bose and Keharia, 2013; Carvalho et al., 2015; Devi et al., 2017) . In this paper we will focus on the third case, where water-immiscible solvents are used in a distinct phase from the aqueous phase, to form a two-liquid phase system. Here the organic solvents are used for substrate supply, or product removal, in order to overcome the low water-solubility of organic compounds and enzyme inhibition by substrate or product. Potentially, the solvent may also be used to overcome an unfavourable equilibrium, although this requires sufficient driving force to be effective. In this way, the application of two-liquid phase systems improves the bioreaction space-time yield (productivity) as well as the product concentration fed to the downstream process, and in some cases the selectivity ( Stepankova et al., 2013) . Both appear to be important, but in many cases the biocatalyst needs to be kept away from the interface. Despite the downside described above the introduction of an organic solvent in the bioreaction system presents several advantages such as the dissolution of substrates and products at higher concentrations in the reactor than would otherwise be achievable. This means that the downstream process can be fed at high concentrations, while avoiding inhibitory concentrations of substrate or product in the aqueous reaction environment (Hua and Xu, 2011; Lima-Ramos et al., 2014). Easier product recovery may also result from the fact that the solvent has a low boiling point, facilitating evaporation (Dafoe and Daugulis, 2014). Likewise when designing an in-situ product removal (ISPR) process, the mode of contact (direct or indirect) between the biocatalyst and the organic phase which removes the product, should be considered (Stark and von Stockar, 2003; Woodley et al., 2008) . A bioreaction system with direct solvent contact can be characterized by the direct exposure of the biocatalyst/cells to the organic solvent [ In Figure 1 , two possibilities for running systems with direct contact are presented: a) corresponds to the exposure of the biocatalyst to organic solvent within the reactor and b) corresponds to the direct contact in a different vessel to the reactor through an external loop. Configuration a) has the advantage that both reaction and product removal take place in the same vessel and therefore the equipment costs are lower. Configuration b) reduces the contact time between the biocatalyst and the organic solvent by introducing an external loop through a separation unit. However, the choice of solvent has to ensure that the solvent does not deactivate the biocatalyst/microorganism and the product has a high enough affinity and solubility. Additionally, two configurations for indirect contact are presented in Figure 1 : c) corresponds to a biphasic reactor with a membrane which separates the two liquid phases and d) corresponds to the separation of the biocatalyst/cells from the reactor medium and use of another vessel for the product removal. In systems such as c) there is usually a physical barrier such as a membrane which prevents the contact of the biocatalyst with the solvent (Stark and von Stockar, 2003; Woodley et al., 2008) . In the configuration d), the biocatalyst/microorganism is never in direct contact with the solvent. The biocatalyst/microorganism is separated from the product and is recycled to the reactor. The medium with product dissolved, in its turn, enters a liquid-liquid extraction unit where the product is partitioned to the organic solvent and the medium that exits the vessel is recycled to the reactor. The choice of solvent for a two liquid-phase system with direct contact is more difficult than for an indirect contact configuration since it must be compatible with the biocatalyst/microorganism and therefore requires a careful study of its toxic effects.
Downstream processing
Organic solvents play an important role as separation and purification agents for small-molecule chemical products from bioprocesses since they allow easy recovery of organic compounds. The use of water as a solvent may present some challenges for downstream processing such as separation difficulties, and its high specific heat capacity implies high energy consumption in distillation and difficulties rapidly heating and cooling (Adams et al., 2003) . Moreover, the solubility of many of the most interesting compounds is often very low in water which implies excessive amounts of water in order to recover small amounts of product, resulting in high costs. When choosing an organic solvent, it should be possible to separate it from the aqueous phase as well as recover the desired products from the solvent as shown in Figure 1 e) (Gu, 2000; Koch, 2015) . This should also enable options for recycling the solvent if viable, which could help optimize the economic feasibility of a given process, due to lower overall solvent use. Nowadays, the recycling of solvents is a common practice in industry. Besides the advantages mentioned above, the separation costs for isolating a product from an organic solvent can be much lower when compared to an aqueous system. The determination of the exact downstream processing conditions depends not only on the nature of the product (solid or liquid) but also on the phase in which the product is primarily soluble. For a two-liquid phase system (i.e. with two immiscible phases), the operation unit mostly used to purify products is liquid-liquid extraction. Concerning energy consumption, liquid-liquid extraction can be more attractive since it is a less energy consuming process compared to distillation and gives a relatively high efficiency for product recovery (Kurzrock and Weuster-Botz, 2010; Stratakos and Koidis, 2016).
Overview of criteria to screen solvents for an industrial bioprocess
The list of solvents applicable to industrial processes is extensive and thus, the choice of the optimum solvent can be a significant challenge. Hence, at an early stage of process development, it is necessary to make a screening of solvents for evaluation of their suitability for the industrial process. Figure 2 shows a screening procedure which is divided in four evaluation categories: (1) environment, health and safety, (2) affinity, recovery and recyclability properties, (3) stability and (4) application. The screening is also divided between tabulated properties which are already available 1 in the literature and experimentally determined properties, which are dependent on the 2 characteristics of the system and have to be experimentally investigated in order to evaluate the its 3 performance.
4
The purpose of the screening procedure is to help narrowing the list of possible solvents to be 5 applied in a bioprocess by evaluating the most important criteria first and eliminating those solvents 6 which do not fulfill the requirements. The methodology starts by evaluating solvents in terms of 7 environment, health and safety issues because this is the greatest concern for process development. Indeed, in order to implement a process it is necessary to fulfill legal and regulatory requirements in 9 this category. Subsequently, solvents are evaluated in terms of recovery and recyclability properties 10 and finally the list is shortened by considering those which fulfill the criteria for application in a 11 given bioprocess.
12
Ultimately an experimental investigation has to be performed since the solvent is selected according 13 to the specific system under study. Nevertheless, some of the listed properties such as Log P o/w 14 provide a direction for the search. The adequate selection of solvents is dependent on their suitability for a given application. 
35
The affinity of a given solvent towards a solute is a fundamental property to consider when 36 choosing a solvent since it determines the viability of the solvent application. Even though this 37 property is very specific for the process, it is possible to find data bases with information for 38 specific solute-extractant pairs such as,(Dortmund Data Bank, 2018). In those cases where the 39 information is not tabulated, the ternary phase behavior can be predicted using thermodynamic can be used for screening solvents and reduce the number of solvents to be tested.
58
The non-precipitation, non-reactivity and chemical stability in the reaction system of the solvent are 59 also important factors to consider (Tzia and Liadakis, 2003) . Likewise the solvent should be stable 60 and not interact with the reaction solutes (e.g. substrate(s) and product(s)) and cause secondary 61 reactions. Needless to say, being able to operate the process safely is of paramount importance.
62
Since most of these properties are dependent on the characteristics of an individual system, 63 experimental work is necessary in order to assess the suitability of the solvent for the process.
64
Therefore, these criteria should be evaluated in the end of the screening process to a very short list 65 of solvents already chosen considering the tabulated properties. There are some specific challenges related to the use of solvents in bioreactions. As mentioned Interestingly, whilst the partition coefficient (Log P o/w ) is an important parameter to assess the 89 suitability for an organic solvent for soluble enzymes, it has also been found useful for immobilized 90 enzyme systems, although with a more relaxed requirements. For example it has been possible to 91 achieve good enzyme performance in biphasic systems using immiscible organic solvents with From the different studies reported, we can conclude that Log P o/w should only be used as a coalescence of emulsions will occur and the easier phase separation will be.
155
In some cases, the direct recovery of a product may not be possible using solvents alone and it is 
Solvent selection guide for biphasic bioreaction systems
An overview of the criteria to take into account when selecting a solvent for a specific application 179 in a process has been described in the preceding sections. In this section, a selection guide for 180 solvents that are, or could potentially be, used in biphasic biocatalytic/fermentation reactions is with operating bioprocesses. In this guide we also provide some examples from the literature which 219 document the use of the solvents in biocatalytic systems and additionally, the enzymes which have 220 been used. Other useful data such as solubility in water, Log P and CAS number are also included.
221
We hope these data will be useful for looking for greener solvents where similar Log P and/or water resistive, and the other solvents as non-resistive. Needless to say, before using any solvents at scale, 241 a full assessment needs to be made of all operational and safety hazards, including resistivity.
242
Where air is used for bio oxidation and/or for transformations with living cells, appropriate care 243 needs to be taken to avoid the formation of an explosive head space if a flammable solvent is used.
244
Since the processes under consideration here are all biphasic, the production of aqueous waste The bioaccumulation criterion corresponds to the bioconcentration factor of a chemical uptake from is less than 1000, the solvent is considered recommended for industrial applications (green).
260
Solvents with bioconcentration factors greater than or equal to 1000 and less than 5000 are 261 considered to be problematic (amber). Solvents with bioconcentration factors higher than 5000 are 262 considered hazardous and not advised to be applied in industrial applications (red) (EPA (U.S.
263
Environmental Protection Agency), 2012).
264
Toxicity to fish is evaluated by the concentration of the solvent which is chronically toxic to fish, there are some differences in the classification of the solvents (Prat et al., 2014) . Moreover, the 297 assessment limits might also change with future legislation. In line with this, we are aware that 298 some solvents which present some toxic and flammable properties (e.g. n-butanol) currently fall 299 into the category of "Recommended" due to the limits of the evaluation. Moreover, azeotrope 300 formation was not considered in the selection guide, although in principle it should also be taken 301 into account when screening for solvents due to separation problems with the recovery of the 302 solvent or waste water treatment. tetrahydrofuran, which were applied greatly in industry in the 90's, are presently being replaced.
347
The three top ranked solvents for industrial application were 2-propanol, ethyl acetate and 348 methanol. The list of the 10 top ranked solvents includes also ethanol, n-heptane, tetrahydrofuran, 2004). Therefore, it is necessary to take this fact into account when considering the application of 398 scCO 2 in processes in which these compounds are substrates or products.
399
The solvent for a process can be chosen from several categories of solvents: water, organic solvents, 
403
In conclusion, the choice of a solvent for a bioprocess should comprise a balance between the 404 effects on the environment, effects on human health, safety hazards, biocatalyst/microorganism 405 activity, solubility and selectivity of substrates and/or products and recovery. This balance is 406 important because it is not always possible to find a solvent which fully covers all these criteria.
407
Problems regarding the impact of a solvent on Environment, Health and Safety are increasingly there has been more focus to substitute the hazardous solvents in already running processes. 
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